U.S. Online Retail and Ecommerce Stock News

Costco Wholesale (NasdaqGS:COST) has lifted its premium club membership fee, its first increase in seven years. Management reports that renewal rates remain over 92% following the fee change. The move highlights Costco's ability to adjust membership pricing while keeping member engagement high. Costco runs a global warehouse club model where membership fees are a core profit driver, often more important than product margins. Against a backdrop of rising operating costs and consumers looking...

Blue Bird (BLBD) has been in focus after reporting record or near-record quarterly revenue and adjusted EBITDA, supported by a larger school bus order backlog, growing electric vehicle demand, and federal funding tied to clean school bus programs. See our latest analysis for Blue Bird. The recent news on strong quarterly results, a growing order backlog and full ownership of Micro Bird sits alongside clear share price momentum. A 30 day share price return of 18.12% and a 1 year total...

NANO Nuclear Energy (NNE) shares are in focus after the U.S. Department of Energy awarded the company a GAIN voucher, supporting safety analysis and regulatory preparation for its KRONOS MMR microreactor design. See our latest analysis for NANO Nuclear Energy. Despite progress on the KRONOS MMR construction permit and the new DOE GAIN voucher, NANO Nuclear Energy’s recent momentum has cooled. The 30 day share price return is 9.03% and the 90 day share price return is 35.97%, while the 1 year...

In recent days, analysts have reiterated mixed views on UWM Holdings, while corporate insider sentiment has turned more positive as senior executives, including President & CEO Mat Ishbia, purchased additional shares. This combination of insider buying and varied analyst opinions is reshaping how investors interpret UWM’s balance between growth ambitions and risk exposure. Next, we’ll examine how this insider buying activity could influence UWM Holdings’ AI-driven growth narrative and...

Why Southwest’s New Profit Target Has Investors Watching Closely Southwest Airlines (LUV) has drawn fresh attention after projecting at least $4 in adjusted profit per share for 2026. This target sits above analyst expectations and contrasts with recent cost and oil price pressures. See our latest analysis for Southwest Airlines. At a share price of US$39.56, Southwest has had a mixed run this year, with a 2.1% 30 day share price return and a 4.2% decline year to date, but a 57.9% 1 year...

Over the last 7 days, the United States market has risen by 3.1%, contributing to a substantial 27% increase over the past year, with earnings forecasted to grow by 16% annually. In this context of robust growth, identifying stocks that may be priced below their estimated value can offer potential opportunities for investors seeking to capitalize on market dynamics and favorable economic conditions.

Over the last 7 days, the United States market has risen by 3.1%, contributing to a substantial 27% climb over the past year, with earnings forecasted to grow by 16% annually. In such a robust market environment, growth companies with high insider ownership can be particularly attractive as they often indicate strong confidence from those closest to the business operations and future prospects.

The market has shown robust performance, rising 3.1% over the last week and 27% over the past year, with earnings expected to grow by 16% annually in the coming years. In light of these conditions, identifying stocks with solid financials can be crucial for investors looking to capitalize on both value and growth opportunities. Penny stocks, despite their somewhat outdated moniker, remain relevant as they often represent smaller or newer companies that can offer significant potential when...

The United States market has been on an upward trajectory, climbing 3.1% in the past week and 27% over the last year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying stocks that combine strong fundamentals with growth potential can uncover promising opportunities for investors seeking to enhance their portfolios.

Over the last 7 days, the United States market has risen by 3.1%, contributing to a remarkable 27% increase over the past year, with earnings expected to grow by 16% annually in the coming years. In such a dynamic environment, reliable dividend stocks that offer attractive yields can provide investors with both income and potential growth opportunities.

In Q4 2025, Xeris Biopharma reported record revenue growth and reached profitability, and guided for over 30% growth in both adjusted EBITDA and total revenue to between US$375 million and US$390 million for 2026, while also filing a patent infringement lawsuit to block generic versions of Recorlev until 2040. This combination of stronger financial performance and efforts to protect Recorlev’s market exclusivity could meaningfully influence expectations for the company’s future cash...

Why Innovex International is drawing fresh investor attention Recent coverage of Innovex International (INVX) is centered on its earnings per share performance, revenue profile, low debt, and profit margins versus peers, alongside supportive trading trends and stronger market interest. See our latest analysis for Innovex International. At a share price of US$26.51, Innovex International has posted a 16.37% year to date share price return and a 74.98% total shareholder return over the past...

Ceasefire relief and China momentum put Ralph Lauren in focus The recent ceasefire in Iran, which helped lift global equity markets and luxury names, has put fresh attention on Ralph Lauren (RL) after a 6.9% one day move in the stock. See our latest analysis for Ralph Lauren. Ralph Lauren's share price has pulled back 1.37% in the latest session to US$379.87 after a sharp move higher. However, the 30 day share price return of 14.86% and 1 year total shareholder return of 90.49% still point to...

Why IQVIA’s recent moves are drawing fresh attention IQVIA Holdings (IQV) has been back in focus after launching its IQVIA.ai platform with NVIDIA, buying drug discovery assets from Charles River Laboratories, and teaming up with the Duke Clinical Research Institute. These moves, along with ongoing share buybacks and IQVIA’s top ranking on Fortune’s World’s Most Admired Companies list, are prompting investors to reassess how the stock’s current return profile lines up with its life sciences...

In March 2026, Li Auto reported delivering 41,053 vehicles, with cumulative deliveries reaching 1.64 million, and resolved production bottlenecks that allowed the Li i6 to exceed 24,000 monthly deliveries. The company paired this operational progress with the rollout of advanced autonomous driving technology, expanded ESG and climate reporting, and an ongoing share repurchase program, highlighting simultaneous execution across products, technology, sustainability, and capital...

DocuSign has integrated its Intelligent Agreement Management platform directly into Slack, allowing users to create, negotiate, and execute contracts inside Slack conversations. The integration focuses on keeping agreement workflows within the same channel where teams already communicate and collaborate. For investors tracking NasdaqGS:DOCU, this product update arrives after a period of weaker share performance. The stock last closed at $42.89, with returns of a 10.7% decline over the past...

Atour Lifestyle Holdings (ATAT) is back on traders’ radar after a fourth quarter earnings beat, a technical rating upgrade, and easing geopolitical tensions that have drawn investors toward travel and consumer names. See our latest analysis for Atour Lifestyle Holdings. At around $36.13, the stock has cooled after its recent rally, with a 30 day share price return of 2.53% against a weaker 90 day patch and a 1 year total shareholder return of 54.66%. This suggests that longer term momentum...

In early April 2026, Keysight Technologies introduced Keysight Assembly, a virtual process simulation tool that helps manufacturers detect assembly issues earlier in development to avoid costly late-stage failures and production delays. By linking stamping simulations with pre-production scan data and shop-floor process modeling, Keysight Assembly offers manufacturers a single workflow that can cut reliance on trial-and-error prototyping and improve build accuracy without requiring...

Earlier in April 2026, Ubiquiti reported quarterly results with earnings per share and revenue above analyst expectations, alongside recognition for strong profitability, financial health, and growth metrics. This combination of an earnings beat and third-party acknowledgement of quality and capital efficiency has sharpened investor focus on Ubiquiti’s underlying business strength. With this backdrop and Ubiquiti’s recent earnings beat, we’ll examine how the news reshapes the company’s...

Earlier this month, Travel + Leisure gained attention after President Trump's Truth Social post confirmed a two-week suspension of military action in Iran, easing geopolitical concerns that had been weighing on the broader travel and vacation space. This pause in tensions raised expectations for lower energy costs and more affordable travel, which could improve the appeal and profitability of vacation offerings across the industry. We’ll now examine how easing geopolitical tensions and the...

Carrier Global (CARR) is back in focus after its share price reacted to easing geopolitical tensions, with potential Israel Lebanon talks supporting a ceasefire and lifting sentiment toward home building and HVAC exposed names. See our latest analysis for Carrier Global. The recent 1 day share price return of 3.06% caps a sharp 7 day gain of 13.94%, while the 1 year total shareholder return of 6.04% sits against a stronger 3 year total shareholder return of 47.55%. This points to momentum...

Azenta, Inc. has appointed Trey Martin as President of its Multiomics business, effective April 6, 2026, succeeding Ginger Zhou, who will remain as an advisor through November 2026 to support the leadership transition. By bringing in an executive with extensive experience scaling genomic platforms and integrating growth investments, Azenta is signaling a sharpened push to advance its Multiomics long-range plan across synthesis capacity, operations, and commercial execution. We’ll now examine...

In late March 2026, Teva Pharmaceutical Industries announced that the US FDA approved PONLIMSI (denosumab-adet) as a biosimilar to Prolia, while regulators in the US and EU accepted the company’s applications for a biosimilar to Xolair (omalizumab), covering all currently approved indications for both reference products. These regulatory milestones mark a meaningful expansion of Teva’s biosimilar footprint in high-need areas such as osteoporosis and severe allergic disease, reinforcing its...

Septerna, Inc. recently began dosing healthy adult volunteers in a Phase 1 single- and multiple-ascending dose clinical trial of SEP-479, an oral small molecule PTH1R agonist being developed for hypoparathyroidism. This marks a key progression of Septerna’s GPCR-targeted pipeline into human testing, with initial safety, PK and PD data expected in late 2026 or early 2027. Next, we’ll examine how initiating human dosing for SEP-479 and its focus on hypoparathyroidism could shape Septerna’s...